AGL:NYE-agilon health Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 4.08

Change

0.00 (0.00)%

Market Cap

USD 1.68B

Volume

3.13M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+3.01 (+0.77%)

USD 101.08B
UHS Universal Health Services Inc

+1.20 (+0.52%)

USD 15.29B
THC Tenet Healthcare Corporation

+4.40 (+2.78%)

USD 14.70B
DVA DaVita HealthCare Partners Inc

+5.92 (+3.76%)

USD 12.58B
EHC Encompass Health Corp

+0.65 (+0.70%)

USD 9.40B
CHE Chemed Corp

+5.54 (+0.97%)

USD 8.57B
NHC National HealthCare Corporatio..

+1.20 (+0.97%)

USD 1.99B
AMN AMN Healthcare Services Inc

+3.46 (+7.92%)

USD 1.66B
BKD Brookdale Senior Living Inc

+0.16 (+2.46%)

USD 1.31B
CYH Community Health Systems Inc

+0.12 (+2.14%)

USD 0.79B

ETFs Containing AGL

VSO:AU Vanguard MSCI Australian .. 1.77 % 0.00 %

+0.77 (+1.16%)

USD 0.97B
OPEN:F iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
OPEN:XETRA iShares VI Public Limited.. 0.00 % 0.00 %

+0.07 (+1.16%)

USD 0.06B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -67.49% 14% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -67.49% 14% F 5% F
Trailing 12 Months  
Capital Gain -77.08% 9% A- 3% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -77.08% 9% A- 3% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -22.30% N/A N/A 3% F
Dividend Return -22.30% N/A N/A 3% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 29.71% N/A N/A 35% F
Risk Adjusted Return -75.05% N/A N/A 3% F
Market Capitalization 1.68B 58% F 64% D

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector